• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Edge Therapeutics’ CEO Brian Leuthner receives EY Entrepreneur of the Year Award

Edge Therapeutics’ CEO Brian Leuthner receives EY Entrepreneur of the Year Award

June 29, 2015
CenterWatch Staff

Brian A. Leuthner, Edge Therapeutics’ CEO, president and co-founder, has received the EY Entrepreneur of the Year 2015 New Jersey Region Award in the Pharmaceutical & Diagnostic Private Companies category. He was selected by an independent judging panel comprising previous winners of the award, CEOs, private capital investors and other regional business leaders.

According to EY, a global provider of assurance, tax, transaction and advisory services, and a division of Ernst & Young, the EY Entrepreneur of the Year award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

As a New Jersey Region award winner, Leuthner now is eligible for consideration for the EY Entrepreneur of the Year 2015 National Award. Award winners in several national categories, as well as the overall EY Entrepreneur of the Year National Award winner, will be announced at the national awards gala in Palm Springs, Calif., in November 2015.

Leuthner co-founded Edge along with R. Loch Macdonald, the company’s chief scientific officer, and Carl J. Soranno in 2009. Leuthner also sits on the company’s board of directors and has more than 25 years of experience in the hospital acute care marketplace, with specific experience in critical care and neurocritical care.

Previously, Leuthner was the CEO of Fontus Pharmaceuticals, the senior head of marketing for The Medicines Company and the director of Market Development for ESP Pharma. He also held marketing and sales positions of significant responsibility at Burroughs Wellcome, GlaxoWellcome and Ortho Biotech. 

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing